Lalit Mohan Sharma

Dr. Lalit Mohan Sharma


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2019 in Cureus
Verified
Journal Article
Open access
PDF file
SPShuchita Pathak
Shuchita Pathak
TSTej P. Soni
Tej P. Soni
LSLalit Mohan Sharma
Lalit Mohan Sharma
NPNidhi Patni
Nidhi Patni
AGAnil K. Gupta
Anil K. Gupta
Aim: To determine the role and efficacy of oral glutamine in the treatment of chemo-radiotherapy-induced oral mucositis and dysphagia in patients with carcinoma of the oropharynx and larynx. The primary objective of this study was to compare the incidence and severity of oral mucositis and dysphagia between the glutamine group (oral glutamine, along with concurrent chemo-radiotherapy) and the control group (concurrent chemo-radiotherapy alone, no glutamine). Secondary objectives were to compare the time to onset of oral mucositis and dysphagia, the incidence of treatment breaks (more than three consecutive radiation fractions missed), and significant weight loss (more than 3 kilograms of weight loss from the baseline) between the two groups. Method: A total of 60 patients with locally advanced carcinoma of the oropharynx and larynx (Stage III - IV) who were receiving concurrent chemo-radiotherapy were randomised to the glutamine group (study arm, n = 30) and the non-glutamine group (control arm, n = 30). All patients were treated by radiotherapy to a total dose of 70 Gy in 35 fractions, along with concurrent weekly injections of cisplatin (40 mg/m2) chemotherapy. Patients in the study arm received 10 gm of oral glutamine two hours before radiotherapy (five days a week during the seven-week course of radiotherapy). In the control arm, glutamine was not given to patients during the chemo-radiotherapy treatment. All patients were assessed for oral mucositis, dysphagia, weight loss, and compliance/gap in the treatment (greater than three consecutive days of radiation missed) until the completion of chemo-radiotherapy. Grading of oral mucositis and dysphagia was done as per the National Cancer Institute, Common Terminology Criteria for Adverse Events version 4.03. Results: Out of 60 patients, 56 patients (93.33%) completed the full course of chemo-radiotherapy treatment. Twenty-seven patients (96.43%) in the control arm developed Grade III oral mucositis compared to only 12 patients (42.83%) in the glutamine arm (p < 0.001). Twenty-six patients (93%) in the control arm developed Grade III dysphagia compared to only 11 patients (39%) in the glutamine arm (p < 0.001). Glutamine significantly decreased the incidence and severity of mucositis and dysphagia. Glutamine delayed the onset of mucositis and dysphagia. As severe dysphagia was more prevalent in the control arm, feeding by Ryle’s tube was required in 17 patients (56.67%) in the control arm versus only in eight patients (26.67%) in the glutamine arm (p = 0.03). Significant weight loss during the treatment was seen in all patients of the control arm (100% patients) compared to only 71% of the patients in the glutamine arm (p = 0.004). In the control arm, 46.67% patients had treatment interruption (gap) compared to 16.67% in the glutamine arm (p = 0.025). Sixteen patients (53%) from the control arm required admission (inpatient care) in the hospital to manage the treatment-toxicity (mucositis and dysphagia) compared to seven patients (23%) from the glutamine arm (p = 0.03). Conclusion: Glutamine significantly decreased the incidence and severity of chemo-radiotherapy-induced oral mucositis and dysphagia. It delayed the onset of oral mucositis and dysphagia, improved the compliance to the chemo-radiotherapy treatment, and reduced the requirement for hospitalization for the management of treatment-induced toxicities in patients with locally advanced carcinoma of the oropharynx and larynx.

18 March 2022 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
Prantar ChakrabartiPrantar Chakrabarti
Prantar Chakrabarti
BGBiju George
Biju George
CSChandrakala Shanmukhaiah
Chandrakala Shanmukhaiah
LSLalit Mohan Sharma
Lalit Mohan Sharma
SUShashank Udupi
Shashank Udupi
WGWaleed Ghanima
Waleed Ghanima
Purpose: Immune thrombocytopenia (ITP) is primarily considered a bleeding disorder; its impact on patients’ health-related quality of life (HRQoL) is under-recognized. We aimed to assess how aligned patient and physician perceptions are regarding ITP-associated symptoms, HRQoL, and disease management in India.Methods: Patients and physicians (hematologists/hemato-oncologists) from India who participated in the global ITP World Impact Survey (I-WISh) were included in this subgroup analysis (survey). Physicians were recruited via a local, third party recruiter in India. In addition to completing a survey themselves, physicians were asked to invite consulting patients on a consecutive basis to complete a survey. All surveys were completely independently by the respondents online in English. The respondents took 30 min to complete the questionnaire. Patients also completed the newly developed ITP Life Quality Index (ILQI) that included 10 questions on the impact of ITP on the following: work or studies, time taken off work or education, ability to concentrate, social life, sex life, energy levels, ability to undertake daily tasks, ability to provide support, hobbies, and capacity to exercise.Results: A total of 65 patients and 21 physicians were included in this study. Average disease duration from diagnosis-to-survey-completion was 5.3 years. The most severe symptoms reported by patients at diagnosis were menorrhagia (15 of 19 patients [79%]), anxiety surrounding unstable platelet counts (17 of 28 patients [61%]), and fatigue (27 of 46 patients [59%]); these were also the key symptoms they wanted to be resolved. In contrast, physicians perceived petechiae (19 of 21 patients [90%]), bleeding-from-gums (8 of 21 patients [86%]), and purpura (16 of 21 patients [76%]) as the most common symptoms. While the important treatment goals for patients were healthy blood counts (42 of 65 patients [65%]), improved QoL (35 of 65 patients [54%]), and prevention of worsening of ITP (33 of 65 patients [51%]), physicians’ goals were reduction in spontaneous bleeding (17 of 21 physicians [81%]), better QoL (14 of 21 physicians [67%]), and symptom improvement (9 of 21 physicians [43%]). More than half the patients reported that ITP affected their work life/studies, social life, and energy levels, thereby negatively impacting their QoL. Patients were almost entirely dependent on family and friends for support.Conclusions: This survey highlights the substantial discrepancy in patients’ and physicians’ perceptions regarding ITP-associated symptoms and treatment goals in India. Based on the identified gaps, educating physicians on aspects of ITP beyond bleeding, and highlighting patients’ under-recognized symptoms/needs through support-systems should be prioritized in the future.

12 February 2024 in South Asian Journal of Cancer
Verified
Journal Article
Open access
PDF file
IMIndu Mohan
Indu Mohan
LSLalit Mohan Sharma
Lalit Mohan Sharma
MKMustak Khan
Mustak Khan
Cervical cancer is second commonest cancer in rural Indian females.[1] This is most preventable cancer due to long biological course, identifiable precancerous lesions, and effective vaccine.[2] [3] Other risk factors are younger age at marriage, number of pregnancies, genital hygiene, and tobacco consumption.[4] In rural areas, most women are illiterate and ignorant about health. Awareness, screening, and early detection lead to improvement in mortality.[1] [5] Our prospective study aimed to establish a community PAP smear lab as part of (demonstrable) healthcare reforms in rural India. This prospective study involved four subcenters under community health center (CHC), Kachola (Bhilwara, Rajasthan), India. Community healthcare experts and oncologists formed the team. Hands-on training for PAP smear collection and staining was done for female healthcare workers. Community leaders were sensitized. Dates for screening camps were decided mutually. A targeted population of 1,970 women aged between 30 and 65 years was enlisted. Government CHC doctors and female community health worker were educated about cervical cancer. Health awareness talks using billboards were delivered. PAP smear was reported by pathologists. Total 197 out of 1,970 (10%) women participated in seven health camps. Most women in the target population remained absent due to fear of loss of daily wages. Majority (90%) of patients aged between 30 and 45 years were daily wagers. Only 60/197 (30.4%) women agreed for PAP smear. None had pathologic abnormalities. Genital tract infections were observed in 79/197 (40%) females. Incidentally, hemoglobin was less than 10 gm/dL in 90% participants. We observed lack of motivation, illiteracy, shyness, and poverty with fear of loss of wages as main barriers. Awareness of the community is major challenge.[1] Successful cancer screening programs need decentralization with focus on rural health centers and incentives. Use of technology in form of mobile smart phone and use of artificial intelligence technology may lead to improve outcome in resource limited setting. Article published online: 12 February 2024 © 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

1 January 2025
Verified
Journal Article
Open access
PDF file
ISIndu Mohan Sharma
Indu Mohan Sharma
LSLalit Mohan Sharma
Lalit Mohan Sharma
ASAryan Mohan Sharma
Aryan Mohan Sharma
SKSrishti Kukreja
Srishti Kukreja
MBMohit Bohra
Mohit Bohra
Introduction - Knowledge, Awareness and Attitude on HPV infection, Vaccine and Cervical Cancer among the school Students in Rajasthan. Cervical cancer is the second commonest cancer among women in rural India. Screening and prophylactic vaccinations against HPV infection bear the potential to reduce the burden of cervical cancer and has been proven a cost-effective method. Limited data is available about awareness and knowledge on HPV infections and vaccination from India . Therefore, this study tries to provide an insight into the awareness and knowledge about HPV infection and vaccination among students of 15 to 30 years of age. Methodology- A cross-sectional study was conducted among school students (6th to 12th) in Ajmer and Jaipur district of Rajasthan from January to December 2023 for students. Data were collected using validated self-administered questionnaires, which consisted of knowledge and perceptions about HPV infection and willingness to get vaccination when available. Descriptive statistics were used to describe the distribution, frequency, and percentage of variables. All analyses were performed with two-sided tests, and a value of p < 0.05 was considered significant. Results -Among 1140 participants only 22.3 % ever heard about the HPV virus. (77.7%) were unaware of HPV, and only 19.5% had heard of the vaccine. Only 17.5% were aware that HPV causes cervical cancer Conclusion- The limited knowledge about cervical cancer and its vaccine among students highlights a critical gap in awareness and education. Addressing knowledge gaps can lead to increased vaccine uptake and reduced disease burden.